Patients are telling the truth — just not to you
September 21, 2026 | Data, Social Listening, clinical trials, patients
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
There’s a familiar complaint in clinical research: patients don’t open up. They say they’re fine when they’re not. They under-report side effects. They nod through the consent conversation, and months later it’s clear they didn’t really follow it.
Spend an hour where patients talk to each other, though, and a different picture appears. They’re not guarded at all. They’re astonishingly honest — about what they fear, the side effects they hide, the days they can barely function. The truth isn’t missing. It’s just pointed somewhere other than the clinic.
That gap between what patients share with one another and what they tell the people providing their care is worth paying attention to. Because the things they don’t say out loud are usually the things a trial team most needs to hear.
What we miss in the room
It’s in patient communities where the quiet parts get said out loud.
On what it takes just to turn up, one person, deep into fertility treatment, wrote that they’d been going so long they had a favourite parking spot and no longer knew how to answer “how are you?” — “I am fine. I am functional.” The “fine” is doing a lot of work there.
On side effects, the honesty is sharper — and more uncomfortable. One cancer patient described hiding their symptoms “so I don’t have to wait another month for the next dose”.
Someone managing chronic pain put it plainly: they don’t tell the doctor about something that helps, “otherwise I’m an addict and not someone who needs help”. That isn’t non-compliance. It’s a calculation — that telling the truth might cost them their treatment.
Patients can also recognise when something isn’t right, sometimes before the clinical picture becomes clear. “The night of the procedure, I knew something was wrong,” one wrote — a concern later confirmed by the tests.
Some of this never gets said in the room. Some of it is said but not fully heard. All of it has value.
The silence isn’t soft — it shows up in your data
It’s tempting to file this under bedside manner. It isn’t. When patients don’t feel safe being honest, the consequences land exactly where a trial can least afford them.
Under-reported side effects create blind spots in safety data. The signals are there, they just aren’t always reaching you. Distress only becomes visible when someone quietly drops out. The burden of participation appears later as missed visits and withdrawals that seem to come from nowhere. A patient saying “I’m fine” isn’t a small social grace; it’s a missing data point. Honesty, in other words, isn’t a courtesy patients owe you. It’s the integrity of what you’re collecting.
Honesty is a design choice, not a personality trait
Patients aren’t withholding because they’re difficult or private. They’re withholding because, somewhere along the way, they learned that honesty has a cost — you lose the drug, you get dismissed, you become “the difficult one”, you worry people who already look worried.
So, the fix isn’t asking harder. It’s making honesty feel safer. That’s a design problem, and it runs through everything a participant touches: how a question is asked, how a reported side effect is met, whether the consent conversation invited questions or just collected a signature, whether the materials treat someone as an expert in their own condition or a beginner. Get those right and people tell you more, not because they suddenly trust strangers, but because the room made candour feel safer.
Start by listening where they’re already honest
If you want to understand what your participants aren’t saying, start where they’re already talking.
The version of the trial experience that rarely reaches the clinic already exists — in the open, in the communities where patients talk to one another. It will tell you which side effects people hide and why, what attending really costs, where the consent process loses them, and what they wish someone had asked. It’s the brief for every conversation you then design.
You don’t need to give people permission to speak openly in the abstract. Start by listening to what they’re already comfortable saying elsewhere. Then build the conditions where they’ll feel just as comfortable saying it to you.
Ready to talk?
Understanding what patients aren’t saying — and designing the materials and moments that help them say it — is what we do. If you want the real version of your participants’ experience, not just the version they feel able to share in clinic, let’s talk.
The patient voice here is drawn from public patient communities in our listening index, de-identified and lightly trimmed; medication names removed. It’s a self-selected, anonymous source — illustrative, not statistically representative — but it shows, in patients’ own words, the honest version they rarely say in clinic.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
New report, The participation equation, uncovers key drivers of patient engagement in clinical trials
Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.
Why patients drop out of weight management trials and what you can do about it
Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.
Cuttsy+Cuttsy welcomes new team members
Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker
Designing with patients in mind: How to build more inclusive clinical trials
Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.
Why fresh patient voices are critical to improve clinical trials outcomes
Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.
Using patient personas to add a personal touch to clinical trial recruitment and retention
Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.
A month of insights: Key takeaways from May’s conferences
Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.
Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report
Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.
Motivations that matter: Understanding clinical trial participation to create better research
Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to…
Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning
Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.